Xencor, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of engineered antibodies for the treatment of cancer and autoimmune diseases. The company provides Ultomiris to treat patients with atypical ...
Q2 2026
Aug 5, 2026
Q1 2026
May 6, 2026
FY 2025
Feb 25, 2026
Q4 2025
Q3 2025
Nov 5, 2025